Octreotide to treat postoperative chylothorax after cardiac operations in children.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 11722081.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chylothorax after pediatric cardiac operations is associated with significant morbidity and increased hospitalization. An octreotide (a synthetic somatostatin analogue) infusion (1 to 4 microg/kg per hour) with medium-chain triglyceride diet or parenteral nutrition was used in 4 pediatric cardiac surgical patients after chylothorax was diagnosed. Resolution followed within 5 days in all without recurrence, while on a normal diet.
Medical subject headings
- Cardiac Surgical Procedures
- Chylothorax
- Octreotide